TANGIBLE PROPERTY LICENSE AGREEMENTTangible Property License Agreement • October 15th, 2019 • Massachusetts
Contract Type FiledOctober 15th, 2019 JurisdictionThis Agreement, effective as of the date set forth above the signatures of the parties below (the "EFFECTIVE DATE"), is between the Massachusetts Institute of Technology ("M.I.T."), a Massachusetts corporation, with a principal office at 77 Massachusetts Avenue, Cambridge, MA 02139-4307 and MetaStat Biomedical, Inc. ("COMPANY"), a corporation organized and existing under the laws of the state of Delaware, with a principal place of business at 8 Hillside Avenue, Suite 207, Montclair, NJ 07042.
ContractTangible Property License Agreement • May 5th, 2020 • Massachusetts
Contract Type FiledMay 5th, 2020 JurisdictionEX-10.18 2 ex10-18.htm ANTIBODY LICENSE AGREEMENT WITH THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY AND ITS DAVID H. KOCH INSTITUTE FOR INTEGRATIVE CANCER Exhibit 10.18 MASSACHUSETTS INSTITUTE OF TECHNOLOGY and COMPANY TANGIBLE PROPERTY LICENSE AGREEMENT TABLE OF CONTENTS
TANGIBLE PROPERTY LICENSE AGREEMENTTangible Property License Agreement • January 10th, 2018
Contract Type FiledJanuary 10th, 2018THIS Agreement is entered into this _______________ day of ____________, 20__ (“Effective Date”) between NORTH CAROLINA STATE UNIVERSITY, a constituent institution of the University of North Carolina and a nonprofit educational and research institution organized under the laws of North Carolina ("NCSU"), having its principal office at Campus Box 8210, Raleigh, North Carolina 27695-8210, and ______________________________________, a corporation organized under the laws of ___________ ("Licensee"), with its corporate headquarters in _________________ and having its principal office at_____________________.
TANGIBLE PROPERTY LICENSE AGREEMENTTangible Property License Agreement • August 26th, 2011 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec • Utah
Contract Type FiledAugust 26th, 2011 Company Industry JurisdictionThis Agreement is entered into by and between the University of Utah Research Foundation, a Utah non-profit corporation having a principal place of business located at 615 Arapeen Drive, Suite 310, Salt Lake City, Utah 84108 (“UURF”), the University of Utah, a body politic and corporate of the State of Utah (“University” and, together with UURF, “Utah”), and Stem Cell Assurances, Inc. (name changed to BioRestorative Therapies, Inc.), a Nevada Corporation having a principal place of business located at 555 Heritage Drive, Suite 130, Jupiter, Florida 33458 (“Licensee”).